Bartholin’s Gland Carcinomas A 20 plus-year experience from Queensland英文文献资料.docVIP

Open Journal of Obstetrics and Gynecology, 2012, 2, 385-388 OJOG /10.4236/ojog.2012.24079 Published Online November 2012 (http://www.SciRP.org/journal/ojog/) Bartholin’s Gland Carcinomas: A 20 plus-year experience from Queensland* 1,2# 1 1 Ian S. C. Jones , Alex Crandon , Karen Sanday 1 2 Queensland Centre for Gynaecological Cancer, University of Queensland, Brisbane, Australia Women’s and Newborn Services, Royal Brisbane and Women’s Hospital, Herston, Australia Email: Ian_Jones@.au # Received 25 June 2012; revised 24 July 2012; accepted 3 August 2012 ABSTRACT Danish anatomist Caspar Bartholin in 1675 [1] and the first description of a Bartholin’s Gland Carcinoma (BGC) was in 1864 [2]. The incidence of Bartholin’s Gland Carcinoma has been variously reported as between two to seven % of all vulvar carcinomas [2]. These tumours can be of long standing because they are misdiagnosed as Bartholin’s gland cysts. When such “cysts” do not re- spond to conservative treatment biopsy reveals the true nature of the condition. Bartholin’s Gland Carcinomas have a wide range of histological features because they may arise from mucinous acini or ductal transitional cell epithelium [3]. Squamous cell carcinomas and adenocar- cinomas each make up between 40% - 45% of Bar- tholin’s Gland Carcinomas [4]. The aim of the study was to review the clinical fea- tures, diagnosis, management and outcomes from the patient records of cases of Bartholin’s Gland Carcinoma held in the Queensland Centre for Gynaecological Can- cer (QCGC) data base and determine if the type of mana- gement altered patient outcome. Objective: To review the records of cases of Bar- tholin’s Gland Carcinoma referred to the Queensland Centre for Gynaecological Cancer (QCGC) between mid 1993 and mid 2012. Methods: Bartholin’s Gland Carcinoma case data f